AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Dual-Labeled E-AB Platform for Continuous, Real-Time Monitoring of Small Molecules

Technology Benefits
Corrects for sensor drift in flowing whole bloodBaseline drift corrections for more than 20 hours
Technology Application
Monitoring of narrow therapeutic index drugs Monitoring specific molecules in complex matrices such as tissue culture Can be used in sensors for the detection of a range of small molecule drugs and metabolites as well as for proteins  Real-time and continuous monitoring of specific molecules in undiluted whole blood
Detailed Technology Description
To combat this, researchers at UC Santa Barbara have created a dual-reporter correction to enhance the performance of electrochemical aptamer-based sensors in whole blood. This sensor architecture paves a way to real-time and continuous metabolic, pharmacokinetic and drug-response measurements. The approach largely eliminates the drift observed for both cocaine and aminoglycoside-detecting E-AB sensors, reducing drift of order 25% - 30% to less than 2% over many hours of continuous operation in flowing, undiluted whole blood.
Others

Background

Historically, several methods have been employed to quantify small molecules and biomarkers in diluted or undiluted blood. However, these methods are very cumbersome and some of them only work for diluted whole blood. Further, they usually fail when applied for real-time, continuous monitoring of the target of interests in whole blood. While such a technology could, for example, provide maximal information about drug levels in blood throughout the day and enable sensitive, real-time dose adjustments and optimal treatment decisions for the patients, achieving this has proven difficult as the design and preparation molecular sensors that can be used in whole blood for real-time and long-term measurements has proven very challenging.


Additional Technologies by these Inventors


Tech ID/UC Case

27069/2016-99M-0


Related Cases

2016-99M-0

*Abstract
A dual-reporter correction to enhance the performance of electrochemical aptamer-based sensors in whole blood.
*Principal Investigator

Name: Netzahualcoyotl Arroyo Curras

Department:


Name: Di Kang

Department:


Name: Kevin Plaxco

Department:


Name: Francesco Ricci

Department:


Name: Hui Li

Department:

Country/Region
USA

For more information, please click Here
Mobile Device